0000950170-24-047018.txt : 20240423
0000950170-24-047018.hdr.sgml : 20240423
20240423170003
ACCESSION NUMBER: 0000950170-24-047018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240423
DATE AS OF CHANGE: 20240423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Michaud Charles Jr
CENTRAL INDEX KEY: 0001999011
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 24865576
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Q32 Bio Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-999-0232
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Homology Medicines, Inc.
DATE OF NAME CHANGE: 20151228
4
1
ownership.xml
4
X0508
4
2024-03-25
true
0001661998
Q32 Bio Inc.
QTTB
0001999011
Michaud Charles Jr
Q32 BIO INC.
830 WINTER STREET
WALTHAM
MA
02451
false
true
false
false
See Remarks
false
Common Stock
2024-03-25
4
S
false
75
24.20
D
927
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.
On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.
Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc.
/s/ Charles Michaud, Jr.
2024-04-23